Cardiol Therapeutics Inc T.CRDL

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

[Jonathon Brown]

The calmer market environment of summer holidays is a prime opportunity for investors to evaluate portfolios and consider new investments. read article.

[PressRelease]

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of...read article.

[whytestocks]

News; $CRDL Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDTToronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol

[PressRelease]

Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of...read article.

[Royal10]

CRDL: new Cannacord price target: $8.00 and WELL: TD tgt= $8.00!

[PressRelease]

(NewsDirect)In a phenomenal year marked by over +180% gains in its stock price, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) added another feather to its cap last week with the announcement of its Phase II MAvERIC-Pilot study topline results. The Canadian biotechnology company has...read article.

[Hideaway]

I've seen junior biotechs get hit on news but this seems extreme to be off 85 cents on a pretty positive NR.Hope it is only a one day affair. Tomorrow should provide some indication. May take a

[Alim33]

This explains the big jump in the last few days. Now, is it sell on news? I certainly hope that this is not the case. GLTA.

[PressRelease]

Administration of CardiolRx™ led to a marked reduction in the primary efficacy endpoint of pericarditis painCardiolRx™ also shown to reduce inflammation in patients with elevated CRP89% of patients have continued into the extension phase of the studyToronto, Ontario--(Newsfile Corp. - June 13...read article.

[PressRelease]

(NewsDirect)Compared to their non-orphan counterparts, orphan drugs have consistently outpaced growth and have become a major part of pharma’s mainstream business. The U.S. FDA's orphan drug designation, established under the Orphan Drug Act of 1983, encourages the development of treatments for...read article.

[Alim33]

Hope not too much profit taking near the end of the day! Don't ruin the momentum!

[Alim33]

Sorry, I jinxed this with my posting and started a pull back. Hopefully, it is over and we'll start moving again.

[Alim33]

Sorry, wrong place!

[Alim33]

Around $1.25 is probably the bottom before the next leg up. GLTA.

[ltdaccess]

Shush, don't tell anybody... better without that kind of unnecessary drama.  I was in around the same time, late February and watched it drop at first.  Had been moving at a good pace

[Alim33]

Got in February averaging $2 and now up over 85%. Hardly any activities on this forum. I.e., no pumpers and/or shorters around!